SEVREDOL Safety Questions, SEVREDOL Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about SEVREDOL. Our extensive database of SEVREDOL adverse events and SEVREDOL warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about SEVREDOL
SEVREDOL Safety Reports
Total SEVREDOL reports: 3.SEVREDOL FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 3.
Take SEVREDOL Side Effects Survey or Share Your SEVREDOL Story. Read More Here.
Consumer or non-health professional from reported SEVREDOL problem on Jan 31, 2007. Female patient, 88 years of age, was diagnosed with back pain and was treated with SEVREDOL. After drug was administered, patient experienced the following problems/side effects: acidosis, confusional state, leukocytosis, renal failure acute, renal tubular necrosis, shift to the left. SEVREDOL dosage: unknown. During the same period patient was treated with DURAGESIC, METAMIZOLE, CALCITONIN, MASTICAL, FOSAMAX, ASPIRIN, ADOLONTA, ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient died on 11/28/2006.
SEVREDOL problem was reported by a Consumer or non-health professional from FRANCE on Dec 04, 2006. Male patient, 61 years of age, weighting 147.7 lb, was diagnosed with liver transplant, aspergillosis and was treated with SEVREDOL. After drug was administered, patient experienced the following problems/side effects: ascites, aspergillosis, blood bilirubin increased, blood creatinine increased, coagulation factor v level decreased, creatinine renal clearance decreased, encephalopathy. SEVREDOL dosage: unknown. During the same period patient was treated with DAFALGAN, NEORAL, CELLCEPT, VFEND, ROVALCYTE, CORTANCYL, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported SEVREDOL problem on July 16, 2007. Male patient, 84 years of age, was diagnosed with pain and was treated with SEVREDOL. After drug was administered, patient experienced the following problems/side effects: confusional state, fatigue, hypotension, miosis. SEVREDOL dosage: 10 MG, UNK. During the same period patient was treated with SKENAN, NEURONTIN. Patient was hospitalized. Patient recovered.